Literature DB >> 14600205

Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment.

Jürgen Krauss1, Michaela A E Arndt, Andrew C R Martin, Huaitian Liu, Susanna M Rybak.   

Abstract

A prerequisite for the enrichment of antibodies screened from phage display libraries is their stable expression on a phage during multiple selection rounds. Thus, if stringent panning procedures are employed, selection is simultaneously driven by antigen affinity, stability and solubility. To take advantage of robust pre-selected scaffolds of such molecules, we grafted single-chain Fv (scFv) antibodies, previously isolated from a human phage display library after multiple rounds of in vitro panning on tumor cells, with the specificity of the clinically established murine monoclonal anti-CD22 antibody RFB4. We show that a panel of grafted scFvs retained the specificity of the murine monoclonal antibody, bound to the target antigen with high affinity (6.4-9.6 nM), and exhibited exceptional biophysical stability with retention of 89-93% of the initial binding activity after 6 days of incubation in human serum at 37 degrees C. Selection of stable human scaffolds with high sequence identity to both the human germline and the rodent frameworks required only a small number of murine residues to be retained within the human frameworks in order to maintain the structural integrity of the antigen binding site. We expect this approach may be applicable for the rapid generation of highly stable humanized antibodies with low immunogenic potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600205     DOI: 10.1093/protein/gzg096

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  11 in total

1.  Directed evolution methods for overcoming trade-offs between protein activity and stability.

Authors:  Samuel D Stimple; Matthew D Smith; Peter M Tessier
Journal:  AIChE J       Date:  2019-10-09       Impact factor: 3.993

2.  A Novel Anti-CD22 scFv.Bim Fusion Protein Effectively Induces Apoptosis in Malignant B cells and Promotes Cytotoxicity.

Authors:  Zahra Mohammadi; Somayeh Enayati; Najmeh Zarei; Samaneh Saberi; Ladan Mafakher; Mohammad Azizi; Vahid Khalaj
Journal:  Appl Biochem Biotechnol       Date:  2022-07-15       Impact factor: 3.094

3.  Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.

Authors:  Jennifer S Michaelson; Stephen J Demarest; Brian Miller; Aldo Amatucci; William B Snyder; Xiufeng Wu; Flora Huang; Samantha Phan; Sharon Gao; Adam Doern; Graham K Farrington; Alexey Lugovskoy; Ingrid Joseph; Veronique Bailly; Xin Wang; Ellen Garber; Jeff Browning; Scott M Glaser
Journal:  MAbs       Date:  2009-03-11       Impact factor: 5.857

4.  Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.

Authors:  Adalbert Krawczyk; Michaela A E Arndt; Ludger Grosse-Hovest; Wilko Weichert; Bernd Giebel; Ulf Dittmer; Hartmut Hengel; Dirk Jäger; Karl E Schneweis; Anna M Eis-Hübinger; Michael Roggendorf; Jürgen Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

5.  High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.

Authors:  Tobias Weber; Benedikt Bötticher; Walter Mier; Max Sauter; Susanne Krämer; Karin Leotta; Armin Keller; Anne Schlegelmilch; Ludger Grosse-Hovest; Dirk Jäger; Uwe Haberkorn; Michaela A E Arndt; Jürgen Krauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

6.  The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan.

Authors:  Seiji Kawa; Masanori Onda; Mitchell Ho; Robert J Kreitman; Tapan K Bera; Ira Pastan
Journal:  MAbs       Date:  2011-09-01       Impact factor: 6.440

Review 7.  Antibody Fragments as Probe in Biosensor Development.

Authors:  Dirk Saerens; Lieven Huang; Kristien Bonroy; Serge Muyldermans
Journal:  Sensors (Basel)       Date:  2008-08-08       Impact factor: 3.576

8.  Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus.

Authors:  Mark Schütte; Philippe Thullier; Thibaut Pelat; Xenia Wezler; Philip Rosenstock; Dominik Hinz; Martina Inga Kirsch; Mike Hasenberg; Ronald Frank; Thomas Schirrmann; Matthias Gunzer; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

9.  A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.

Authors:  Tobias Weber; Athanasios Mavratzas; Stefan Kiesgen; Stephanie Haase; Benedikt Bötticher; Evelyn Exner; Walter Mier; Ludger Grosse-Hovest; Dirk Jäger; Michaela A E Arndt; Jürgen Krauss
Journal:  J Immunol Res       Date:  2015-10-28       Impact factor: 4.818

10.  Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.

Authors:  Pietro Della Cristina; Monica Castagna; Alessio Lombardi; Erika Barison; Giovanni Tagliabue; Aldo Ceriotti; Ilias Koutris; Luana Di Leandro; Francesco Giansanti; Riccardo Vago; Rodolfo Ippoliti; Sopsamorn U Flavell; David J Flavell; Marco Colombatti; Maria Serena Fabbrini
Journal:  Microb Cell Fact       Date:  2015-02-13       Impact factor: 6.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.